SCD and type 2 diabetes mellitus: This study is the first to detail the serum profiles of miRNAs and mRNAs in women with T2DM and their effects on fracture risk, and to suggest that SCD1 could be beneficial in the treatment of diabetic patients at high risk of fracture.